Vitamin D and genomic stability

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 475, Issue 1-2, 2001, Pages 69-87

  Chatterjee, Malay ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

Genomic stability; Vitamin D

Indexed keywords

CALCITRIOL; CYCLINE; MESSENGER RNA; MYC PROTEIN; OSTEOPONTIN; PROLACTIN; PROTEIN C FOS; PROTEIN C JUN; SIALOPROTEIN; VITAMIN D RECEPTOR;

APOPTOSIS; BLOOD LEVEL; CALCIUM HOMEOSTASIS; CELL PROLIFERATION; CHROMOSOME ABERRATION; CHROMOSOME STRUCTURE; DIETARY INTAKE; DNA STRAND BREAKAGE; DNA SYNTHESIS; GENE ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENOTOXICITY; HORMONE RECEPTOR INTERACTION; HUMAN; HYPOGONADISM; NONHUMAN; OSTEOLYSIS; OXIDATIVE STRESS; PHOSPHORYLATION; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TISSUE DISTRIBUTION; VITAMIN D DEFICIENCY;

EID: 0035906323     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(01)00080-X     Document Type: Review

References (122)

1. Bcl-2 prevents caspase-independent cell death
2. 2+ transport in chick perfused duodenum
3. 3 receptors: Gene regulation and genetic circuitry
4. 3 receptor in mouse fibroblasts
5. Polyamines
6. Extra-endocrine functions of Vitamin D
7. Facilitated calcium diffusion by intestinal Ca-binding protein
8. Vitamin D and adaptation to dietary calcium and phosphate deficiencies increase intestinal plasma membrane calcium pump gene expression
9. Vitamin D, calcium and epidermal differentiation
10. 3 potentates the keratinocyte response to calcium
11. 3 on human lymphocytes and monocytes/macrophages: Inhibition of IL-2 and augmentation of IL-1 production
12. The immunobiology of Vitamin D
13. Vitamin D-soltriol. The heliogenic steroid hormone: Somatotropic activator and modulator. Discussion from histochemical studies led to new concepts
14. 3 on parathyroid hormone decrease, adenosine 3′,5′-monophosphate release and ultrastructure of parathyroid glands in organ culture
15. Vitamin D and its relevance to cancer
16. 3 in GH4cl cells
17. Antioxidant functions of carotenoids
18. Antioxidant action of carotenoids
19. The structural mimicry of membrane steroids by tamoxifen: Evidence from cholesterol coefficients and molecular modeling for its action as a membrane antioxidant and an anticancer agent
20. Tamoxifen and related compounds decrease membrane fluidity in liposomes. Mechanisms of antioxidant action of tamoxifen and relevance to its anticancer and chemopreventive actions
21. Vitamin D is a membrane antioxidant. Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action
22. Free radical-induced biological damage and the critical roles of Vitamin A, Vitamin C, Vitamin D and Vitamin E and of copper, iron, selenium and zinc
23. 3 and Vitamin E on peroxidation of lipids and enzymes of the hepatic antioxidant system in Sprague-Dawley rats
24. Vitamins A, C, D and E
25. Glutathione metabolism and its selective modification
26. Apoptosis induced by Vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53
27. 3 analogue (KH 1060) with 9-cis-retinoic acid irreversibility inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells
28. Death receptor: Signalling and modulation
29. 3, retinoic acid and dexamethasone
30. 3, in human breast cancer cells
31. 3 derivatives and breast-tumor cell growth: Effect on intracellular calcium and apoptosis
32. Changes in c-myc expression and the kinetics of dexamethane induced programmed cell death (apoptosis) in human lymphoid leukemia cells
33. Thapsigargin-induced persistent intracellular calcium-pool depletion and apoptosis in human hepatoma cells
34. EB 1089, a synthetic analogue of Vitamin D, induces apoptosis in breast cancer cells in vivo and in vitro
35. New Giemsa method for the differential staining of sister chromatids
36. Betancourt, Sister chromatid exchange (SCE) and cell proliferation in lymphocytes from infected and non-infected children with severe calorie malnutrition (PCM)
37. Mutator phenotype may be required for multistage carcinogenesis
38. Latent expression of p53 mutations and radiation-induced mammary cancer
39. Genomic instability induced by ionizing radiation
40. Chromosome aberration and cancer
41. Non-random chromosomal changes in human neoplasia
42. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogen
43. Non-random distribution of mutagen-induced chromosome breaks in lymphocytes of patients with different malignancies
44. Chromosomal aberrations in mice induced by aluminium chloride
45. 3 in murine lymphoma
46. Effects of anti-oxidants on oxidant-induced sister chromatid exchange
47. Guidelines for the conduct of micronuclease assay in mammalian bone marrow erythrocytes
48. The in vivo micronucleus assay in mammalian bone marrow and peripheral blood. A report of the U.S. Environmental Protection Agency gene-tox programme
49. β-carotene inhibits rat liver chromosomal aberrations and DNA-chain break after a single injection of diethylnitrosamine
50. 3
51. Human diseases associated with defective DNA repair
52. Signal pathways for Vitamin D-induced differentiation, implications for therapy of proliferative and neoplastic diseases
53. Vitamin D stimulates DNA synthesis in alveolar type II cells
54. 1,25-Dihydroxyvitamin D3 suppress cell growth, DNA synthesis and phosphorylation of retinoblastoma protein in a breast cancer cell line
55. Alterations in rat epidermis provoked by chronic Vitamin D deficiency
56. Genetic disorders of Vitamin D biosynthesis
57. 3 in vitro synthesis by human decidua and placenta
58. Altered expression of bone sialoproteins in Vitamin D-deficient rBBSP2.7Luc transgenic mice
59. Regulation of the parathyroid hormone gene by Vitamin D, calcium and phospate
60. 3 in vivo
61. Vitamin D toxicity. Initial site and mode of action
62. Vitamin D is an important factor in estrogen biosynthesis of both female and male gonads
63. 3
64. Human genetic susceptibility to tuberculosis
65. 3 responding gene
66. Structure function relationships in the Vitamin D endocrine system
67. Geographic variation in breast cancer mortality in the United States: A hypothesis involving exposure to solar radiation
68. Serum 25-hydroxyvitamin D and colon cancer: Eight-year prospective study
69. Is Vitamin D deficiency a risk factor for possible for prostate cancer (Hypothesis)?
70. 3 a novel immunoregulatory hormone
71. 3 enhances the growth of tumors in athymic mice inoculated with receptor rich osteosarcoma cells
72. 3 in the proliferation of a human colon cancer cell line in vitro
73. Development of inhibitors of protein farnesylation as potential chemotherapeutic agents
74. Induction of gap junctional intercellular communication by Vitamin D in human skin fibroblasts is dependent on the nuclear Vitamin D receptor
75. Gap junction communication and neoplastic transformation
76. The connexin 43 gene is responsive to estrogen
77. 3 reduces their tumorigenecity: A model for cancer chemoprevention
78. 3-treated animals
79. kip1 gene promoter that lacks Vitamin D response elements
80. 3 precedes down regulation of the c-myc genes
81. The role of the Vitamin D endocrine system in health and disease
82. Influence of Vitamin D status on the early hepatic response to carcinogen exposure to rats
83. Hypocalcemia decreases the early and late responses to epidermal growth factor in rat hepatocyts
84. Vitamin D and adaptation to dietary calcium and phosphate deficiencies increase intestinal plasma membrane calcium pump gene expression
85. 3 and cardiovascular function in rats
86. Changes in the kinetics of muscle contraction in Vitamin D-depleted rats
87. Vitamin D deficiency, hypocalcemia and increased skeletal muscle degradation in rats
88. A human retinoic acid receptor which belongs to the family of nuclear receptors
89. Molecular cloning of complementary DNA encoding the avian receptor for Vitamin D
90. Interaction between retionic acid and Vitamin D signaling pathways
91. Positive and negative interaction of 1,25-dihydroxyvitamin D3 and the retinoid CD437 in the induction of human melanoma cell apoptosis
92. 3 and the retinoid CD437 in the induction of human melanoma cell apoptosis
93. Vitamin A antagonizes the action of Vitamin D in rats
94. The metabolism of heavy metals depend on the Vitamin D status of the body
95. 3 inhibit diethylnitrosamine induced rat liver carcinogenesis
96. 3 suppresses the effect of streptozotocin-induced diabetes during chemical rat liver carcinogenesis
97. Vanadium chemoprevention of 7,12-dimethylbenz (a) anthracene-induced rat mammary carcinogenesis: Probable involvement of representative hepatic phase I and II xenobiotic transformation
98. An evaluation of the reactive contributors of exposures to sunlight and of diet to the circulation concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston
99. Vitamin D metabolism and biological actions
100. 3 inhibit placental glutathione S-transferase positive foci in rat liver carcinogenesis
101. 3 on carcinogen-modified liver enzymes and tumor incidence in experimental rat mammary carcinogenesis
102. Influence of dietary calcium and Vitamin D on diet-induced epithelial cell hyperproliferation in mice
103. Prevention of bone loss by Vitamin D supplementation in elderly women: A randomised double-blind trial
104. The effect of Vitamin D supplementation on the bone mineral density of the femoral neck is associated with Vitamin D receptor genotype
105. Exogenous calciferol (Vitamin D) and Vitamin D endocrine status among elderly nursing home residents in New York City area
106. Gains in bone mineral density with resolution of Vitamin D intoxication
107. 3 and dihysdroachysterol 3
108. A new mechanism for Vitamin D deficiency in calcium deprivation
109. Expression of 25-hydroxy Vitamin D3-254-hydroxylase activity in coco-2-cells. In vitro model of intestinal Vitamin D catabolism
110. Factors in human Vitamin D nutrition and in the production and cure of classical rickets
111. Vitamin D supplementation, 25-hydroxyvitamin D concentrations and safety
112. Vitamin D from skin: Contribution with oral Vitamin D in normal and anticonvulsant treated subjects
113. Competitive binding assay for Vitamin D and 25-OH Vitamin D
114. 25-Hydroxyvitamin D levels in patients treated with high-dosage ergo- and cholecalciferol
115. Vitamin D metabolism in patients intoxicated with ergocalciferol
116. Hypercalcemia and hyperosteolysis in Vitamin D intoxication: Effects of clodronde therapy